Pro Nephro AKI (NGAL) is now FDA-Cleared     READ MORE

Antibodies

Fueling scientific, pharmaceutical, and clinical research and assay development.

Thoroughly Tested and Characterized

BioPorto antibodies are frequently used to develop diagnostic immunoassays within several disease areas, including immunodeficiency, allergy, coagulation, diabetes, kidney, and cardiovascular disease.

All are mouse monoclonal antibodies, affinity purified, and thoroughly tested to ensure low-to-no batch-to-batch variation.

Allergy

The HE1 IgE is an affinity-purified, fully human IgE antibody with kappa light chains produced in vitro from a monoclonal hybridoma. This source minimizes the risk of contamination from other immunoglobulin isotypes and ensures high reproducibility.

Immunodeficiency

Develop assays that will defend the body against pathogens such as bacteria, viruses, and other microorganisms. Our antibodies accurately target pivotal areas within the tree main pathways of the complement system: the classical pathway, the MBL pathway, and the alternative pathway.

Diabetes and Obesity

Expand your diabetes and obesity research and assay development with a wide range of gut hormone antibodies – appetite stimulating and appetite suppressing. BioPorto’s GLP-1 antibodies target several epitopes in different forms with high specificity, giving valuable insight into the action mechanism of GLP-1.

Kidney Disease

Investigate nephrotoxicity and other sources of nephropathy with unique NGAL antibodies available in six different species from mouse to man.

Antibody Licensing

BioPorto seeks to strengthen and expand our product portfolio with unique antibodies. If you have monoclonal antibodies that you would like to make available to researchers, please contact us to learn more about our track record and in licensing agreement options.